SARS-CoV-2 Virus Reduction

Varun Dwivedi, Jun-Gyu Park, Stephen Grenon, Nicholas Medendorp, Cory Hallam, Jordi B. Torrelles,
Texas Biomedical Research Institute - San Antonio, TX
Full Report


To evaluate the efficacy and the dose response of NuvaWave Instant UV handheld device in reducing the SARS-CoV-2 virus on surfaces.


SARS-CoV-2 was dried on a chambered glass slides and introduced in a NuvaWave robotic testing unit. The programed robotic unit facilitated the exposure of pre-determined UVC radiation dose to the virus for 1, 2, 4 and 8 seconds. Post-UVC exposure, virus was recovered and titered by plaque assay in Vero E6 cells.

Summary of Results

The NuvaWave handheld device deactivated 99.88% of SARS-CoV-2 after one second of exposure.

Contact Us

USA Headquarters
3540 Toringdon Way, Suite 200 Charlotte, NC  28277
1 866 508 1118

Ireland Headquarters
DCU Innovation Campus
Old Finglas Road
Glasnevin, Dublin D11 KXN4
+353 1 907 2750